Document is current
Any future updates will be listed below
-
Authors
Kariuki, Christopher Kinyanjui
Doijen, Jordi
Mann, Mandeep Kaur
Xie, Jiexiong
Van Loock, Marnix
Van Damme, Ellen
-
Funding
Funding for this research was provided by:
Janssen Research and Development
The Office of the Administration for Strategic Preparedness and Response, Biomedical Advanced Research and Development Authority (OTA number HHSO100201700018C)
- License Information
-
More Information
Article History
Received: 27 November 2025
Accepted: 29 March 2026
First Online: 10 April 2026
Declarations
:
: Not applicable.
: Not applicable.
: Ellen Van Damme, Jordi Doijen, Mandeep Kaur Mann, Christopher Kinyanjui Kariuki, Marnix Van Loock, Jiexiong Xie are/were employees of Johnson & Johnson and may own stock or stock options from Johnson & Johnson.
